The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
Protocol Amendment History
5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2026-01-20; most recent amendment 2026-07-02.
Status change: Active, Not Recruiting → Completed2026-03-23
Status change: Recruiting → Active, Not Recruiting2026-03-10
Status change: Not Yet Recruiting → Recruiting2026-02-16